25 results
424B5
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Prospectus supplement for primary offering
5:27pm
compensation, including golden parachute compensation; and
an exemption from the auditor attestation requirement in the assessment of our internal … with the auditor attestation requirements in the assessment of our internal control over financial reporting;
reduced disclosure obligations regarding executive
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Jan 24
Current report (foreign)
7:43am
estimate of the amount expected to be payable under a residual value guarantee, if we change our assessment of whether we will exercise a purchase
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
21 Dec 23
Current report (foreign)
7:34am
symptoms. This segment of the study will involve the longitudinal assessment of samples, aiming to discern specific phenotypic T-cell profiles
424B3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
20 Dec 23
Prospectus supplement
4:03pm
to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting;
reduced disclosure
F-3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
5 Dec 23
Shelf registration (foreign)
4:06pm
Condition and Results of Operations in our filings with the SEC;
not being required to comply with the auditor attestation requirements in the assessment … with the SEC;
not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial
6-K
EX-99.1
wbh1hymtlx8ss97dsb
12 Sep 23
Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar
7:49am
6-K
EX-99.1
4jsv2ejqojkw mso
19 Apr 23
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
8:32am
424B3
dhoon18
31 Mar 23
Prospectus supplement
4:04pm
424B3
08l3ll4ytsrggsj
2 Dec 22
Prospectus supplement
4:17pm
F-1
vdgv4x
18 Nov 22
Registration statement (foreign)
5:39pm
6-K
EX-10.3
1mfv vxld
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
20-F
k97hx nmnjno2
12 Aug 22
Annual report (foreign)
4:20pm
6-K
EX-99.1
ptxhoewbd6uefw7yaa7j
26 Jul 22
Current report (foreign)
7:36am
424B4
b6f81
21 Jul 22
Prospectus supplement with pricing info
10:01am
F-1/A
j4td rrhpx
24 Jun 22
Registration statement (foreign) (amended)
9:47pm
F-1/A
gvkr97pnj12q 6xq
24 Jun 22
Registration statement (foreign) (amended)
8:21am
F-1/A
zay4dnfo8uv
21 Jun 22
Registration statement (foreign) (amended)
6:26am
F-1/A
fd2n0o
6 Jun 22
Registration statement (foreign) (amended)
6:13pm
F-1/A
xccjmhg4s a6q8
11 May 22
Registration statement (foreign) (amended)
3:11pm